ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Tobacco Council Awards 34 New Grants

April 16, 1982

Centers May Become More specialized, Klausner Tells AACI

April 26, 1996

Feinstein Slams Cancer Act Proposal, Calls White Paper Vague And Unrealistic.

October 19, 2001

CCIRC Reviews Two Existing, One Prospective Cooperative Group

March 4, 1977

NCAB May Make Its Recommendation On Comprehensive Center Issues At September Meeting

August 5, 1988

Obey Questions NCI honesty, Transfers IARC Monograph Support To NIH

October 15, 1982